Pandemic forces Proteus into bankruptcy - MassDevice

Proteus Digital Healthproteus-digital-health has filed for Chapter 11 bankruptcy protection, noting that its efforts to raise money or sell the company fell victim to the COVID-19 pandemic.

The Redwood City, Calif.-based company missed a $100 million funding target in December. Once valued at $1.5 billion, Proteus previously raised $420 million from investors including Novartis Venture Fund and Kaiser Permanente Ventures, according to an April report by Forbes.

Proteus’ products combine oral medications with an ingestible sensor. The sensor-embedded pill was approved by the FDA in November 2017. Otsuka Pharmaceutical (TYO:4578) and Proteus developed the Abilify MyCite pill to treat schizophrenia, manic and mixed episodes linked with bipolar I disorder and depression in adults. Otsuka and Proteus signed an $88 million deal in 2018 in which Proteus would help Otsuka develop more digital medicines while commercializing the smart pill technology.

The first cancer patients were treated using its digital oncology therapy in January 2019. At the time, company had also launched a digital oral oncolytic medication registry to gather real-world data from cancer patients using digital medicines.

In January of this year, Proteus announced a multi-year, outcomes-based deal with the state of Tennessee’s Medicaid program, TennCare, to support TennCare-covered patients undergoing hepatitis C treatment with medication adherence and stronger connections to their care teams.

“Filing for bankruptcy protection allows Proteus to continue its sales process in a more concerted and efficient manner while continuing to run the business as usual,” the company said in an email to MassDevice.

Corporations that file for Chapter 11 bankruptcy protection are not necessarily quitting the business. The protection from creditors is designed to allow them to restructure and regain their financial footing.

The bankruptcy filing in U.S. District Court in Delaware lists 20 creditors, most of whom Proteus owe less than $500,000. They include Romaco North America, a global supplier of pharmaceutical tableting and packaging technologies ($510,848); Otsuka ($397,721); drug manufacturer Xcelience ($215,616); investment bank B. Riley FBR ($98,789); and Robert Bosch North America ($50,000).

In the filing, Proteus said it and its advisors “commenced a robust marketing process to secure additional funding or bids for a sale of the Debtor’s business. Despite having several promising opportunities, the onset of the COVID-19 pandemic created significant uncertainty in the capital markets and frustrated the Debtor’s efforts. However, the Debtor has had fruitful discussions with Otsuka and other interested parties regarding a potential sale transaction.”

The company said it anticipates that it will seek approval of bidding and sale procedures in the early weeks of the bankruptcy case, according to the filing. It employs 93.






RSS From Medical Design & Outsourcing

  • Why FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google.
    In this week’s episode of DeviceTalks Weekly, co-hosts Chris Newmarker and Tom Salemi dig into the recent successes by start-ups Circadia Health and Preceptis Medical, which both saw expedited approval from the FDA due to the pandemic. Circadia Health earned a spot on this year’s “20 medical device startups you need to know” list. Circadia… […]
  • 20 medical device startups you need to know
    The medtech industry isn’t immune from COVID-19 troubles, but exciting innovation continues. These 20 medical device startups have grabbed our attention. Tom Salemi, DeviceTalks Editorial Director and Sean Whooley, Assistant Editor A number of medical device startups continue to make waves across the space, with new technologies and eye-watering fundraising rounds highlighting some exciting prospects.… […]
  • $4.2m project with GE would develop air transport vital-signs patch
    The Nano-Bio Materials Consortium (NBMC) announced this week that it has launched a project with GE Research to develop a medical-grade wireless patch that monitors the vital signs of medical patients during emergency air transport. The device would advance medical care coordination, records management and patient outcomes in aeromedical evacuation and help drive advances in… […]
  • 5 medical device industry supplier innovations you should know
    Innovative medical devices from original equipment manufacturers (OEMs) get a lot of press. But many of those devices wouldn’t exist if it weren’t for innovative contract manufacturers and suppliers. Working with materials as pliable as as polyester and as strong as stainless steel, these companies are always innovating to create new or improved components that… […]
  • Texas governor halts elective procedures in populous counties
    Citing the need to preserve hospital beds for COVID-19 patients, Texas Gov. Greg Abbott today issued an executive order halting elective medical procedures in the state’s four most heavily populated counties . The order, issued this morning, covers the counties of Bexar, Dallas, Harris and Travis counties. Bexar County includes the city of San Antonio. Houston… […]
  • Moderna, Catalent partner on COVID-19 vaccine candidate manufacturing
    Moderna (NSDQ:MRNA) and Catalent (NYSE:CTLT) today announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine candidate (mRNA-1273) at Catalent’s biologics facility in Bloomington, Ind. Catalent will provide vial filling and packaging capacity, as well as additional staffing required for 24×7 manufacturing operations at the site to support production of an initial 100 million doses… […]
  • Report: New U.S. reshoring agency may loan billions for manufacturing
    The head of the newly formed U.S. International Development Finance Corp. (DFC) said this week that the agency could provide tens of billions of dollars in financing to return manufacturing to the United States, according to a report by Reuters. One of the projects it may finance is a $12 billion semiconductor plant from Taiwan, DFC CEO… […]
  • Webinar: How to protect your medical device manufacturing workers from COVID-19
    Tuesday, July 21, 2020 11:30 a.m. Eastern time / 8:30 a.m. Pacific time     As essential medtech facilities continue operations during COVID-19 and more facilities resume manufacturing, employee safety becomes a very important topic. In this webinar we will explore how to protect your medical device manufacturing workers from COVID-19. The most important step… […]
  • Webinar: How to boost value while reducing the billing cost of your diagnostics
    Thursday, July 30, 2020 2 p.m. Eastern time / 11:30 a.m. Pacific time     Why is it so vital for your organization to understand and maximize its value, even if it’s not in a buying or selling mode? The diagnostics industry — including medical device companies, remote patient monitoring firms, and independent diagnostic testing… […]
  • Biomerics opens online medical balloon store
    Interventional and radiology device contract manufacturer Biomerics announced today that it has launched an online store to sell medical balloons. The new e-commerce platform will sell a range of off-the-shelf nylon, PET, and LDPE medical balloons, enabling engineers to develop and prototype next-generation catheters quickly, according to the Salt Lake City-based company. The online store… […]
  • How to protect connected medical devices from cyberattacks
    Today’s connected-health solutions have dramatically improved patient care. Ensuring that they simultaneously protect patients from hackers requires a closer look at their security, especially as they move to command-and-control models using commercial smartphones. Vinay Gokhale, Thirdwayv No one doubts that connecting medical devices in the Internet of Things (IoT) has delivered many benefits that have… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.